Intrinsiqq
Alpha Cognition Inc. logo

Alpha Cognition Inc. Insider Trading

ACOG

⊜ Compare
Last 12 months

Insiders bought 116K on the open market and sold nothing.

Net open-market
+116K
2 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
2 / 0
executives and directors
Last open-market buy
Aug 2026
Aug 21, 2026

Get an email when ACOG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 22 – 23
    Opaleye Management Inc.
    Large holder · bought 32,090 at avg $8.28
    266K
    1.0% of stake
  • Oct 15 – 16
    Opaleye Management Inc.
    Large holder · bought 36,940 at avg $8.35
    309K
    1.1% of stake
  • Oct 1
    Opaleye Management Inc.
    Large holder · bought 19,050 at $8.69
    166K
    0.6% of stake
  • Sep 24 – 25
    Opaleye Management Inc.
    Large holder · bought 31,763 at avg $8.53
    271K
    1.0% of stake
  • Sep 14 – 16
    Opaleye Management Inc.
    Large holder · bought 123,918 at avg $8.57
    $1.06M
    3.9% of stake
  • Aug 21
    Robert James Wills
    Director · bought 10,000 at $9.62
    96K
    45% of stake
  • Jul 31 – Aug 3
    Opaleye Management Inc.
    Large holder · bought 52,900 at avg $8.00
    423K
    1.7% of stake
  • Jul 24
    Opaleye Management Inc.
    Large holder · bought 130 at $7.90
    1K
    <0.1% of stake
  • Jul 22 – 23
    Opaleye Management Inc.
    Large holder · bought 200,086 at avg $7.82
    $1.57M
    6.9% of stake
  • Jun 25 – 26
    Opaleye Management Inc.
    Large holder · bought 152,533 at avg $6.40
    976K
    5.6% of stake
  • Jun 11 – 15
    Opaleye Management Inc.
    Large holder · bought 7,685 at avg $5.96
    46K
    0.3% of stake
  • Jun 9 – 10
    Opaleye Management Inc.
    Large holder · bought 30,728 at avg $5.98
    184K
    1.1% of stake
  • Jun 5
    Opaleye Management Inc.
    Large holder · bought 10,054 at $5.83
    59K
    0.4% of stake
  • May 27 – 29
    Opaleye Management Inc.
    Large holder · bought 73,738 at avg $5.90
    435K
    2.8% of stake
  • May 20 – 21
    Opaleye Management Inc.
    Large holder · bought 24,376 at avg $5.77
    141K
    0.9% of stake
  • May 19
    Lauren D'Angelo
    Chief Operating Officer · bought 3,500 at $5.76
    20K
    2.6% of stake
  • May 15 – 18
    Opaleye Management Inc.
    Large holder · bought 34,043 at avg $5.76
    196K
    1.3% of stake
  • Mar 27 – 30
    Opaleye Management Inc.
    Large holder · bought 11,850 at avg $5.07
    60K
    0.5% of stake
  • Mar 24 – 26
    Opaleye Management Inc.
    Large holder · bought 20,082 at avg $5.41
    109K
    0.8% of stake
  • Mar 18 – 19
    Opaleye Management Inc.
    Large holder · bought 4,575 at avg $5.73
    26K
    0.2% of stake
  • Mar 16
    Opaleye Management Inc.
    Large holder · bought 1,331 at $5.78
    8K
    <0.1% of stake
  • Mar 12 – 13
    Opaleye Management Inc.
    Large holder · bought 13,066 at avg $5.79
    76K
    0.5% of stake
  • Mar 6 – 9
    Opaleye Management Inc.
    Large holder · bought 4,079 at avg $5.83
    24K
    0.2% of stake
  • Mar 4 – 5
    Opaleye Management Inc.
    Large holder · bought 66,818 at avg $5.80
    388K
    2.7% of stake
  • Mar 2 – 3
    Opaleye Management Inc.
    Large holder · bought 71,411 at avg $5.76
    412K
    3.0% of stake
  • Feb 26 – 27
    Opaleye Management Inc.
    Large holder · bought 4,228 at avg $5.99
    25K
    0.2% of stake
  • Feb 20 – 24
    Opaleye Management Inc.
    Large holder · bought 171,410 at avg $5.86
    $1M
    7.8% of stake
  • Aug 18, 2025
    Robert James Wills
    Director · bought 15,000 at $8.49
    127K
    New position
  • Aug 18, 2025No plan
    Phillip Joseph Mertz
    Director · sold 27,778 at $9.00
    250K
    44% of stake
  • Aug 18, 2025
    Leonard Powell Mertz
    Director · bought 27,778 at $9.00
    250K
    12% of stake
  • Nov 13, 2024
    Michael E. McFadden
    Chief Executive Officer · bought 2,608 at $5.75
    15K
    23% of stake
  • Nov 13, 2024
    Leonard Powell Mertz
    Director · bought 8,695 at $5.75
    50K
    3.9% of stake
  • Nov 13, 2024
    John Prentiss Havens
    Director · bought 4,347 at $5.75
    25K
    1.5% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ACOG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ACOG

CompareIntrinsic value
LCTXLineage Cell Therapeutics Inc.
$1.03+1.98%10
ALECAlector Inc.
$2.28+11.22%10
CRSPCrispr Therapeutics AG
$51.78+3.57%40
ELUTElutia Inc.
$0.76-6.52%20
CRBUCaribou Biosciences, Inc.
$0.44-3.27%10
RLAYRelay Therapeutics Inc.
$18.03+3.38%40
LENZLENZ Therapeutics, Inc.
$3.46-1.14%10
XFORX4 Pharmaceuticals Inc.
$3.24+2.21%20

Spot a number that looks wrong? Check it in ACOG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ACOG

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.